Results 21 to 30 of about 12,501 (219)

Breast Cancer Risk with Progestin Subdermal Implants: A Challenge in Patients Counseling

Frontiers in Endocrinology, 2021
There is a steady global rise in the use of progestin subdermal implants, where use has increased by more than 20 times in the past two decades. BC risk has been reported with the older progestin only methods such as oral pills, injectables, and ...
Ghada Mohammed, Noha A. Mousa, Iman M. Talaat, Iman M. Talaat, Haya Ibrahim, Maha Saber-Ayad, Maha Saber-Ayad   +6 more
doaj   +1 more source

The Cost-Effectiveness of Emergency Hormonal Contraception with Ulipristal Acetate versus Levonorgestrel for Minors in France.

PLoS ONE, 2015
ObjectiveTo evaluate the cost-effectiveness of ulipristal acetate and levonorgestrel in minors in France, and analyze whether it is worthwhile to provide ulipristal acetate to minors free of charge.MethodsThe cost-effectiveness of two emergency ...
Ramona Schmid
doaj   +1 more source

Two Cases of Acute Cholecystitis and Symptomatic Choledocholithiasis in Two Women Less than 40-Years-of-Age with Hormonal Intrauterine Devices

Case Reports in Gastrointestinal Medicine, 2018
Levonorgestrel uterine implants are accepted as a safe and efficacious method of contraception. One of the two major health side effects in a large controlled study of subcutaneous hormonal implants with levonorgestrel was a significant increase in ...
Helen M. Shields, Hasrat Sidhu
doaj   +1 more source

Levonorgestrel-Intrauterine Device for Chronic Pelvic Pain: Decreasing Menstrual Frequency, But Not Surgical Intervention Prior to Insertion, Predicts Improved Pain Scores

, 2021
Levonorgestrel-Intrauterine Device for Chronic Pelvic Pain: Decreasing Menstrual Frequency, But Not Surgical Intervention Prior to Insertion, Predicts Improved Pain ...
I Conroy (13449150), A Fitzgerald (9865709), I Jakab (13448868), S Mooney (13449153), S Grover (9883580), J Porter (7939469), N Origanti (13448883), M Sewell (13448892), S Maxwell (13448877), M Duff (13448865), A McCutchan (13449162), S Madden (7755818), Shane Kavanagh (13094145), K Robertson (13324230), K Mirowska--Allen (13449165), A Quinless (13449156), S Nair (13448880)   +16 more
core  

Pharmacokinetics of levonorgestrel and etonogestrel in rat or minipig following intravenous, subcutaneous, or intradermal administration

, 2022
The objective of these studies was to determine the pharmacokinetics of levonorgestrel and etonogestrel in Sprague-Dawley rat or Göttingen minipig following various administration routes.Four sequential crossover studies were conducted: Study 1 ...
Don M. Gibson (13545647), Louis L. Radulovic (13545644), Mark A. Milad (13545641), Paul J. Ko (13545638)   +3 more
core   +1 more source

COMPARATIVE ANALYSIS OF REQUIREMENTS FOR QUALITY CONTROL OF ETHINYL ESTRADIOL AND LEVONORGESTREL CONTAINING MEDICINAL PRODUCTS

Регуляторные исследования и экспертиза лекарственных средств, 2018
The article compares test methods and levels of requirements laid out in the world’s leading pharmacopoeias and in manufacturers’ specifications with regard to the quality of levonorgestrel and ethinyl estradiol containing medicinal products used as oral
V. I. Seredenko, A. V. Korolev, L. G. Maslov, T. Yu. Belova, N. N. Dolgushina   +4 more
doaj   +1 more source

Acne resolution rates: Results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara (R)) and EE/LNG (Microgynon (R)) [PDF]

, 2001
Background and Objective: Acne in women can often be successfully treated by the intake of oral contraceptives containing gestagens with anti-androgenic properties.
Zahradnik, H. P., Arp, W., Andreas, J. O., Binder, N., Worret, I.   +4 more
core   +1 more source

Efficacy of cyclic and extended regimens of ethinylestradiol 0.02 mg ‐levonorgestrel 0.09 mg for dysmenorrhea: A placebo‐controlled, double‐blind, randomized trial

Reproductive Medicine and Biology, 2021
Purpose We aimed to evaluate the efficacy and safety of 28‐day Cyclic and 84‐day Extended regimens of NPC‐16 (ethinylestradiol 0.02 mg plus levonorgestrel 0.09 mg) in patients with dysmenorrhea.
Tasuku Harada, Mikio Momoeda
doaj   +1 more source

Coexisting adenomyosis in endometriosis: Similar pain and quality of life, with longer bleeding and bowel symptoms—A comparative cross‐sectional study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To compare pain, menstrual flow, and quality of life (QoL) between women undergoing surgery for endometriosis only compared with women with endometriosis and coexisting adenomyosis. Methods A cross‐sectional study, set in two tertiary hospitals, of reproductive‐aged women (18–50 years) with a preoperative imaging diagnosis of ...
Mariana Matzenbacher Brunoro, Ana Clara Pimenta Servidoni, Sofia Di Nur Wakabayashi, Camila Rebeque Dagola, Marina Paula Andres, Mauricio Simoes Abrao   +5 more
wiley   +1 more source

The Levonorgestrel Intrauterine Device is Effective as Emergency Contraception

, 2021
Emergency contraception prevents pregnancy after sexual intercourse. The FDA has approved two "morning-after" pills for this purpose, and the copper intrauterine device (IUD) is an order of magnitude more effective than these oral options.
Turok, D.; Simmons, R.; Kaiser, J.; Gawron, L.; Sanders, J.
core